News & Publications
Stanford Cancer Institute News
CAR-T Cell Therapy in Solid Tumors
CAR-T therapy has shown a great benefit in patients with hematologic and lymphatic cancers. However, applying the therapy to solid tumors has proven to be challenging. One of the barriers is T cell exhaustion, where the CAR-T cell becomes dysfunctional.
Meryl Selig has had a unique experience at the Stanford Cancer Institute (SCI). She began as a patient volunteer in 2009 before being diagnosed with cancer and becoming a patient. She became one of the first patients to receive a novel chimeric antigen receptor (CAR-T) cell therapy when she enrolled in a phase-one clinical trial in 2023.
The Stanford Cancer Institute Early Drug Development program awarded for increasing clinical trial access
The Stanford Cancer Institute Early Drug Development (EDD) program brings in early-phase clinical trials so cancer patients can have access to innovative treatments that could provide a therapeutic benefit.
2024 Tandem Meetings | Transplantation & Cellular Therapy Meeting of ASTCT and CIBMTR
Stanford has 10 presenters at the 2024 Tandem Meetings | Transplantation & Cellular Therapy Meeting of ASTCT and CIBMTR.
Stanford Medicine News: Cancer
A Stanford Medicine study identifies an easily measured biophysical property that can identify Type 2 diabetics at increased risk for liver cancer who don’t meet current screening guidelines.
Treatment of metastatic disease is responsible for nearly one-third of the decrease in annual deaths from breast cancer from 1975 to 2019, according to a Stanford Medicine-led study.
Circulating tumor DNA predicts recurrence and splits disease into two subgroups in Stanford Medicine-led study of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity.
Pancreatic cancer is deadly, and its toll is growing. Scientists find that scar tissue around the tumor suggests how long a patient will live after diagnosis.
Stanford University News: Cancer
- – Stanford Report
Shared facilities remove roadblocks to research - Stanford Report
Shared facilities give Stanford’s scientists easier access to state-of-the-art equipment – and push the boundaries for how it can be used.